Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ergosterol is the primary sterol found in the cytoplasmic membranes of fungi, serving a role analogous to cholesterol in animal cells (Lofgren & Nielsen, 2017). It is essential for maintaining membrane integrity, fluidity, and the proper functioning of membrane-bound enzymes and transporters (Alvarez et al., 2007). Ergosterol-rich domains, often referred to as fungal lipid rafts, act as platforms for signaling and protein trafficking, including the localization of cell wall synthesis machinery (Douglas & Konopka, 2014). Because ergosterol is absent in mammalian cells, it represents a critical target for antifungal therapy (Odds et al., 2003). Polyene antibiotics, such as amphotericin B, exert their effect by binding directly to ergosterol, creating transmembrane pores that cause the leakage of essential intracellular components like potassium ions (Gray et al., 2012). Recent studies also suggest that polyenes act by sequestering ergosterol into 'sponge-like' aggregates, which physically extracts the sterol from the membrane and disrupts cellular function (Anderson et al., 2014). This dual mechanism leads to rapid fungicidal activity against a broad spectrum of pathogens (Ghannoum & Rice, 1999).
Direct binding to ergosterol molecules within the fungal membrane, resulting in the formation of aqueous pores that cause the leakage of intracellular ions (e.g., K+, Mg2+) and subsequent cell death (Gray et al., 2012). Additionally, the sequestration of ergosterol into large aggregates disrupts the organization of ergosterol-rich domains (lipid rafts), impairing the function of membrane-bound proteins (Anderson et al., 2014).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cytoplasmic membrane ergosterol.